2019 Maryland Code
Health - General
Title 21 - Food, Drugs, and Cosmetics
Subtitle 2C - Prescription Drug Affordability Board
§ 21-2C-11. Funding source.
(a) On or before December 31, 2020, the Board shall determine a funding source for the Board.
(b) In determining a funding source, the Board shall consider:
(1) Assessing and collecting a fee on manufacturers, pharmacy benefits managers, health insurance carriers, wholesale distributors, or other entities;
(2) Using rebates the State or local government receives from manufacturers; and
(3) Any other method it determines appropriate for funding the Board.
(c) On or before December 31, 2020, in accordance with § 2–1257 of the State Government Article, the Board shall report back to the Senate Finance Committee and the House Health and Government Operations Committee with a recommendation on legislation necessary to establish a funding source for the Board.
(d) The Board shall be established using general funds, which shall be repaid to the State with the funds from the funding source determined by the Board under subsection (a) of this section.
